Evogene Ltd. (EVGN)
| Market Cap | 33.33M |
| Revenue (ttm) | 5.64M |
| Net Income (ttm) | -23.88M |
| Shares Out | 50.58M |
| EPS (ttm) | -0.52 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 69,152 |
| Open | 0.650 |
| Previous Close | 0.650 |
| Day's Range | 0.640 - 0.669 |
| 52-Week Range | 0.450 - 1.440 |
| Beta | 1.16 |
| Analysts | Strong Buy |
| Price Target | 3.62 (+449.4%) |
| Earnings Date | May 23, 2024 |
About EVGN
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, su... [Read more]
Financial Performance
In 2023, Evogene's revenue was $5.64 million, an increase of 236.72% compared to the previous year's $1.68 million. Losses were -$23.88 million, -10.36% less than in 2022.
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for EVGN stock is "Strong Buy." The 12-month stock price forecast is $3.62, which is an increase of 449.40% from the latest price.
News
Evogene Schedules First Quarter 2024 Financial Results Release
Zoom conference call scheduled for 9:00 AM ET REHOVOT, Israel , May 9, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize...
Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
Preliminary data from Biomica's Phase 1 study of BMC128 will be showcased at the conference REHOVOT, Israel , April 16, 2024 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company de...
Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting
REHOVOT, Israel , April 11, 2024 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd.
Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry
Finally Foods is financed by the Israeli Innovation Authority (IIA) and The Kitchen Hub, and will be granted a license to utilize Evogene's AI technology REHOVOT, Israel , April 2, 2024 /PRNewswire/ -...
Evogene Announces Filing of Annual Report on Form 20-F
REHOVOT, Israel , March 28, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science-based product discovery and d...
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
REHOVOT, Israel , March 20, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN) (the "Company", "Evogene"), a leading computational biology company targeting to revolutionize life-science pro...
Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing
REHOVOT, Israel , March 19, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company that develops microbiome-based, computational-driven bio-stimulant and bio-pesticide novel products an...
Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculant, in Regenerative Agriculture Initiatives in North America
REHOVOT, Israel , March 13, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company that develops microbiome-based, computational-driven bio-stimulant and bio-pesticide novel products an...
Evogene Reports Fourth Quarter and Full Year 2023 Financial Results
Conference call and webcast: today, March 7, 2024, 9:00 am E.T. +1-888-407-2553 or +972-3- 9180608 I https://veidan.activetrail.biz/evogeneq4-2023 REHOVOT, Israel , March 7, 2024 /PRNewswire/ -- Evoge...
AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides
REHOVOT, Israel , March 6, 2024 /PRNewswire/ -- AgPlenus Ltd., a global leader in designing and developing novel sustainable crop protection products and a subsidiary of Evogene Ltd.
Casterra Announces New Agreements with Seed Producers in Brazil and Africa to Meet Growing Demand for its Elite Castor Seed Varieties
The new agreements are expected to support additional production of approximately 400 tons of Casterra's elite castor seeds in 2024 and establish long-term production infrastructure REHOVOT, Israel , ...
Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements
The payment completes the $5M advance payment received under the licensing agreement for bio-fungicide product candidates REHOVOT, Israel , Feb. 28, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-b...
Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024
Conference call scheduled for 9:00 AM ET REHOVOT, Israel , Feb. 26, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize li...
AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive Officer
REHOVOT, Israel , Feb. 22, 2024 /PRNewswire/ -- AgPlenus Ltd, a global leader in designing and developing novel sustainable crop protection products, and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (T...
AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control Solution
The collaboration will tap into the potential of artificial intelligence (AI) to design and optimize crop protection chemistry, developing a novel sustainable Mode-of-Action (MoA) broad-spectrum herbi...
Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-Insecticide
Agreement reinforces both companies' commitment to developing and bringing innovative biological solutions to farmers BASEL, Switzerland and REHOVOT, Israel , Feb. 20, 2024 /PRNewswire/ -- Syngenta Cr...
Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation
The parties will identify and design probiotic bacteria that produce highly sustainable quantities of microbial metabolites, known to improve human health and vitality BOSTON and REHOVOT, Israel , Feb...
Biomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement Summit
REHOVOT, Israel , Jan. 23, 2024 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd.
Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug
The final patient completes Phase I trial enrollment, evaluating safety and tolerability for Biomica's microbiome-based immuno-oncology drug, BMC128 REHOVOT, Israel , Jan. 17, 2024 /PRNewswire/ -- Bio...
Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024
REHOVOT, Israel , Dec. 21, 2023 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd.
Casterra Appoints New CEO and Expands Team to Drive Growth and Innovation
Mr. Yoash Zohar, a seasoned ag executive, is joining Casterra as CEO to lead the company's significant operational expansion REHOVOT, Israel , Dec. 19, 2023 /PRNewswire/ -- Casterra Ag Ltd., a subsidi...
Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™
The agreement supports Lavie Bio's 2024 sales growth plan for spring wheat, durum, and barley in Canada REHOVOT, Israel , Dec. 5, 2023 /PRNewswire/ -- Lavie Bio Ltd., a subsidiary of Evogene Ltd.
Lavie Bio Announces Expansion of its Bio-Inoculant Product for Spring Wheat, Yalos™, to Durum and Barley
Lavie Bio will offer Yalos™ (formerly Thrivus™) to farmers growing spring wheat, durum and barley across the US and Canada in 2024 REHOVOT, Israel , Nov. 28, 2023 /PRNewswire/ -- Lavie Bio Ltd., a sub...
Evogene Reports Third Quarter 2023 Financial Results
Conference call and webcast: today, November 15, 2023, 9:00 am ET REHOVOT, Israel, Nov. 15, 2023 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aimin...
Lavie Bio Reports Advancement in Bio-Fungicide Program Against Downy Mildew with 2023 Field Trial Results
LAV321, discovered and optimized by Lavie Bio, delivered positive results in 2023 field trials across Europe and the US, protecting against downy mildew REHOVOT, Israel , Nov. 8, 2023 /PRNewswire/ -- ...